BioSpace News Archive

Tegoprubart, Eledon Pharmaceuticals’ experimental anti-CD40L antibody, was part of the immunosuppressive treatment regimen used following the first-ever transplant of a kidney from a genetically modified pig to a human.

Despite meeting its primary endpoint in a late-stage generalized myasthenia gravis trial, Roche and Chugai Pharmaceutical’s Enspryng did not demonstrate clinical benefit as expected, the companies announced Thursday.

Duvyzat, which will be sold in the U.S. by ITF Therapeutics, joins a growing market that includes recently approved gene therapy Elevidys and corticosteroid Agamree.

Oprah Winfrey this week shone the spotlight on these transformative GLP-1 medications. Now, it’s time for Medicare to cover them and expand access to millions of Americans.

At Thursday’s Pharma Media Day, Bayer touted Nubeqa as the fastest growing androgen receptor inhibitor in the U.S., which will achieve blockbuster status this year.

Following its label expansion earlier this month, Medicare on Thursday said it will now cover the use of Novo Nordisk’s Wegovy in patients with overweight or obesity who have preexisting cardiovascular disease.

RELIEF THERAPEUTICS Holding SA announced it has granted an exclusive license to Eton Pharmaceuticals, Inc. for the commercialization of GOLIKE ® family of products in the United States.

Royal Philips, announced it has convened the Annual General Meeting of Shareholders 2024 and published the agenda with explanatory notes.

Zylox-Tonbridge Medical Technology Co., Ltd., a leading medical device company in the peripheral and neurovascular interventional market in China, announced its annual financial results for 2023.

Pharmazz, Inc. (“Pharmazz”), a biopharmaceutical company developing and commercializing drug products to treat critically ill patients, announced that it has entered into a license agreement with Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s”), a global pharmaceutical company, to commercialize a first-in-class innovative drug Centhaquine in India.